AxoGen (AXGN) Tops Q1 EPS by 7c

AxoGen (NASDAQ: AXGN) reported Q1 EPS of ($0.10), $0.07 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $36.7 million versus the consensus estimate of $35.37 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M